Dr. Daniel Landau
Claim this profileOrlando Health Cancer Institute
Studies Prostate Cancer
Studies Renal Cell Carcinoma
6 reported clinical trials
24 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Renal Cell Carcinoma
Stage IV
Affiliated Hospitals
Clinical Trials Daniel Landau is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Lenalidomide +/- Daratumumab
for Multiple Myeloma
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria
More about Daniel Landau
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Daniel Landau has experience with
- Nivolumab
- Ipilimumab
- Docetaxel
- Lenalidomide
- Daratumumab/rHuPH20
- Triptorelin
Breakdown of trials Daniel Landau has run
Prostate Cancer
Renal Cell Carcinoma
Cancer
Tumors
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Landau specialize in?
Daniel Landau focuses on Prostate Cancer and Renal Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Daniel Landau currently recruiting for clinical trials?
Yes, Daniel Landau is currently recruiting for 4 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Daniel Landau has studied deeply?
Yes, Daniel Landau has studied treatments such as Nivolumab, Ipilimumab, Docetaxel.
What is the best way to schedule an appointment with Daniel Landau?
Apply for one of the trials that Daniel Landau is conducting.
What is the office address of Daniel Landau?
The office of Daniel Landau is located at: Orlando Health Cancer Institute, Orlando, Florida 32806 United States. This is the address for their practice at the Orlando Health Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.